期刊
CURRENT OPINION IN PHARMACOLOGY
卷 10, 期 6, 页码 655-661出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2010.08.011
关键词
-
资金
- National Health and Medical Research Council of Australia [458649, 513808, 634375]
- Cancer Council Western Australia
Recent years have seen a massive expansion in our understanding of the biology of microRNAs (miRNAs) in cancer, through the identification of miRNAs with aberrant expression in specific cancers and the functional validation of their critical target molecules and cellular effects In parallel, targeted therapeutic agents to block signalling pathways critical to tumour growth and progression have been developed but have yielded disappointing clinical results The discovery of miRNAs that regulate ErbB signalling in cancer cells brings new hope that in the future these oncogenic pathways can be more effectively inhibited to improve patient outcomes
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据